Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse

Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse / Astrid M.H. Horstman, Evelien M.P. Backx, Joey S.J. Smeets, Gabriel N. Marzuca-Nassr, Janneau van Kranenburg, Douwe de Boer, John Dolmans, Tim Snijders, Lex B. Verdijk, Lisette C.P.G.M. de Groot, Luc J.C. van Loon. - (PLos One 14 (2019) 1 (28 January); p. 1-15)

  • PMID: 30689637
  • PMCID: PMC6349315
  • DOI: 10.1371/journal.pone.0210823


Abstract

Background: A few days of bed rest or immobilization following injury, disease, or surgery can lead to considerable loss of skeletal muscle mass and strength. It has been speculated that such short, successive periods of muscle disuse may be largely responsible for the age-related loss of muscle mass throughout the lifespan.

Objective: To assess whether a single intramuscular injection of nandrolone decanoate prior to immobilization can attenuate the loss of muscle mass and strength in vivo in humans.

Design, setting and participants: Thirty healthy (22 ± 1 years) men were subjected to 7 days of one-legged knee immobilization by means of a full leg cast with (NAD, n = 15) or without (CON, n = 15) prior intramuscular nandrolone decanoate injection (200 mg).

Measures: Before and immediately after immobilization, quadriceps muscle cross-sectional area (CSA) (by means of single-slice computed tomography (CT) scans of the upper leg) and one-legged knee extension strength (one-repetition maximum [1-RM]) were assessed for both legs. Furthermore, muscle biopsies from the immobilized leg were taken before and after immobilization to assess type I and type II muscle fiber cross-sectional area.

Results: Quadriceps muscle CSA decreased during immobilization in both CON and NAD (-6 ± 1% and -6 ± 1%, respectively; main effect of time P<0.01), with no differences between the groups (time × treatment interaction, P = 0.59). Leg muscle strength declined following immobilization (-6 ± 2% in CON and -7 ± 3% in NAD; main effect of time, P<0.05), with no differences between groups (time × treatment interaction, P = 0.55).

Conclusions: This is the first study to report that nandrolone decanoate administration does not preserve skeletal muscle mass and strength during a short period of leg immobilization in vivo in humans.

Original document

Parameters

Science
Study
Date
28 January 2019
People
Backx, Evelien M.P.
Boer, Douwe de
Dolmans, John
Groot, Lisette C.P.G.M. de
Horstman, Astrid M.H.
Kranenburg, Janneau van
Marzuca-Nassr, Gabriel N.
Smeets, Joey S.J.
Snijders, Tim
Van Loon, Lucas J.C. van
Verdijk, Lex B.
Country
Netherlands
Language
English
Other organisations
Maastricht Universitair Medisch Centrum Plus (Maastricht UMC+) - Maastricht University Medical Center+
Wageningen University & Research (WUR)
Doping classes
S1. Anabolic Agents
Substances
Nandrolone (19-nortestosterone)
Medical terms
Health effects
Legitimate Medical Treatment
Document category
Scientific article
Document type
Pdf file
Date generated
5 November 2020
Date of last modification
13 November 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin